Publications

Epidemiology and Demography

Recommendations for Using Health Service Coverage Cascades to Measure Effective Coverage for Maternal, Newborn, Child, and Adolescent Health Services or Interventions.Strong, K. Konstantinou, G. Agweyu, A. Diaz, T. Jackson, D. Kim, M. Kubota, S. Leslie, H. Lazzerini, M. Marchant, T. Munos, M. Muzigaba, M. Quach, A. Sheffel, A. Yaqub, N, Jr. Life Stages Quality of Care Metrics Technical Working Group for Maternal, Newborn Child Adolescent, Health Ageing,
Glob Health Sci Pract, (2024). 12:

Inno4Vac Workshop Report Part 2: RSV-Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK.Waldock, J. Cox, R. J. Engelhardt, O. G. Ascough, S. Osterhaus, A. Rimmelzwaan, G. F. Ludlow, M. Tregoning, J. S. McDonald, J. U. Buchholz, U. J. Jeeninga, R. E. Sande, C. Chiu, C.
Influenza Other Respir Viruses, (2024). 18:e70013

Inpatient and postdischarge mortality among children with anaemia and malaria parasitaemia in Kenya: a cohort study.Ngari, M. Mwangome, M. Ouma, N. Nyaguara, A. Mturi, N. Obiero, C. Kamau, A. Walson, J. L. Iversen, P. O. Maitland, K. Snow, R. W. Berkley, J.
BMJ Glob Health, (2024). 9:

Local patterns of spread of influenza A H3N2 virus in coastal Kenya over a 1-year period revealed through virus sequence data.Owuor, D. C. Ngoi, J. M. Nyasimi, F. M. Murunga, N. Nyiro, J. U. Chaves, S. S. Nokes, D. J. Agoti, C. N.
Sci Rep, (2024). 14:23426

Is fat mass a better predictor of 6-month survival than muscle mass among African children aged 6-59 months with severe pneumonia?.Nalwanga, D. Musiime, V. Kiguli, S. Olupot-Olupot, P. Alaroker, F. Opoka, R. Tagoola, A. Mnjalla, H. Mogaka, C. Nabawanuka, E. Giallongo, E. Karamagi, C. Briend, A. Maitland, K.
BMC Nutr, (2024). 10:130

Spatio-temporal distribution of rhinovirus types in Kenya: a retrospective analysis, 2014.Morobe, J. M. Kamau, E. Luka, M. M. Murunga, N. Lewa, C. Mutunga, M. Bigogo, G. Otieno, N. Nyawanda, B. Onyango, C. Nokes, D. J. Agoti, C. N. Munywoki, P. K.
Sci Rep, (2024). 14:22298

The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.Terstappen, J. Hak, S. F. Bhan, A. Bogaert, D. Bont, L. J. Buchholz, U. J. Clark, A. D. Cohen, C. Dagan, R. Feikin, D. R. Graham, B. S. Gupta, A. Haldar, P. Jalang'o, R. Karron, R. A. Kragten, L. Li, Y. Lowensteyn, Y. N. Munywoki, P. K. Njogu, R. Osterhaus, A. Pollard, A. J. Nazario, L. R. Sande, C. Satav, A. R. Srikantiah, P. Stein, R. T. Thacker, N. Thomas, R. Bayona, M. T. Mazur, N. I.
Lancet Infect Dis, (2024). 24:e747-e761

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.Schilling, W. H. K. Mukaka, M. Callery, J. J. Llewelyn, M. J. Cruz, C. V. Dhorda, M. Ngernseng, T. Waithira, N. Ekkapongpisit, M. Watson, J. A. Chandna, A. Nelwan, E. J. Hamers, R. L. Etyang, A. Beg, M. A. Sow, S. Yavo, W. Allabi, A. C. Basnyat, B. Sharma, S. K. Amofa-Sekyi, M. Yonga, P. Adler, A. Yuentrakul, P. Cope, T. Thaipadungpanit, J. Rienpradub, P. Imwong, M. Abdad, M. Y. Blacksell, S. D. Tarning, J. Goudjo, F. F. Dossou, A. D. Konate-Toure, A. Assi, S. B. Ouffoue, K. Nasronudin, N. Rachman, B. E. Romadhon, P. Z. Dewanto, D. D. Heryana, M. O. Novi, T. Pasaribu, A. P. Mutiara, M. Nasution, M. P. R. Khairunnisa, K. Dalimunthe, F. A. Airlangga, E. Fahrezzy, A. Subronto, Y. Ananda, N. R. Rahardjani, M. Rimainar, A. Lucinde, R. K. Timbwa, M. Onyango, O. E. Agutu, C. Akech, S. Hamaluba, M. Kipyego, J. Ngachi, O. Haidara, F. C. Traore, O. Y. Diarra, F. Khanal, B. Dahal, P. Shrestha, S. Rijal, S. Kabore, Y. Adehossi, E. Guindo, O. Qamar, F. N. Kazi, A. M. Woodrow, C. J. Laird, S. Cheeba, M. Ayles, H. Cheah, P. Y. Taylor, W. R. J. Batty, E. M. Chotivanich, K. Pukrittayakamee, S. Phumratanaprapin, W. von Seidlein, L. Dondorp, A. Day, N. P. J. White, N. J. Copcov Collaborative Group
PLoS Med, (2024). 21:e1004428

Managing hypertension in rural Gambia and Kenya: Protocol for a qualitative study exploring the experiences of patients, health care workers, and decision-makers.Diallo, B. A. Hassan, S. Kagwanja, N. Oyando, R. Badjie, J. Mumba, N. Prentice, A. M. Perel, P. Etyang, A. Nolte, E. Tsofa, B. I. HCoR-Africa Collaborators
NIHR Open Res, (2024). 4:5

The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya.Nyiro, J. U. Nyawanda, B. O. Mutunga, M. Murunga, N. Nokes, D. J. Bigogo, G. Otieno, N. A. Lidechi, S. Mazoya, B. Jit, M. Cohen, C. Moyes, J. Pecenka, C. Baral, R. Onyango, C. Munywoki, P. K. Vodicka, E.
BMC Public Health, (2024). 24:2410

Challenges and Approaches to Establishing Multi-Pathogen Serosurveillance: Findings from the 2023 Serosurveillance Summit.Carcelen, A. C. Kong, A. C. Takahashi, S. Hegde, S. Jaenisch, T. Chu, M. Rochford, R. Kostandova, N. Gurley, E. S. Wesolowski, A. Azman, A. S. van der Klis, F. R. M. den Hartog, G. Drakeley, C. Heaney, C. D. Winter, A. K. Salje, H. Rodriguez-Barraquer, I. Leung, D. T. Njenga, S. M. Kagucia, E. W. Jambo, K. C. Wolter, N. Charles, R. C. Saboya-Diaz, M. I. Martin, D. L. Moss, W. J.
Am J Trop Med Hyg, (2024). 111:1145-1152

A Phase I trial of Non-invasive Ventilation and seizure prophylaxis with levetiracetam In Children with Cerebral Malaria Trial (NOVICE-M Trial).Maitland, K. Obonyo, N. Hamaluba, M. Ogoda, E. Mogaka, C. Williams, T. N. Newton, C. Kariuki, S. M. Gibb, D. M. Walker, A. S. Connon, R. George, E. C.
Wellcome Open Res, (2024). 9:281

Phylogeography and reassortment patterns of human influenza A viruses in sub-Saharan Africa.Owuor, D. C. de Laurent, Z. R. Oketch, J. W. Murunga, N. Otieno, J. R. Nabakooza, G. Chaves, S. S. Nokes, D. J. Agoti, C. N.
Sci Rep, (2024). 14:18987

Evaluating the implementation of the Primary Health Integrated Care Project for Chronic Conditions: a cohort study from Kenya.Mugo, R. Pliakas, T. Kamano, J. Sanga, L. A. Nolte, E. Gasparrini, A. Barasa, E. Etyang, A. Perel, P.
BMJ Public Health, (2024). 2:e000146

Legume-supplemented feed for children hospitalised with severe malnutrition: a phase II trial.Walsh, K. Kiosa, A. Olupot-Olupot, P. Alaroker, F. Okiror, W. Nakuya, M. Tssenyondo, T. Aromut, D. Okalebo, B. C. Muhindo, R. Mpoya, A. George, E. C. Frost, G. S. Maitland, K.
Br J Nutr, (2024). 132:372-381

STRIKE-HBV: establishing an HBV screening programme in Kilifi, Kenya-challenges, successes and lessons learnt.Downs, L. O. Chirro, O. Zaharani, M. Safari, B. Okanda, D. Githinji, G. Andersson, M. I. Newton, R. Etyang, A. Aliyan, N. Matthews, P. C.
Sex Transm Infect, (2024). 100:325-328

Tungiasis among children in Kenya is associated with poor nutrition status, absenteeism, poor school performance and high impact on quality of life.Elson, L. Kamau, C. Koech, S. Muthama, C. Gachomba, G. Sinoti, E. Chondo, E. Mburu, E. Wakio, M. Lore, J. Maia, M. Adetifa, I. Orindi, B. Bejon, P. Fillinger, U.
PLoS Negl Trop Dis, (2024). 18:e0011800

Nutritional supplementation in children with severe pneumonia in Uganda and Kenya (COAST-Nutrition): a phase 2 randomised controlled trial.Kiguli, S. Olupot-Olupot, P. Hamaluba, M. Giallongo, E. Thomas, K. Alaroker, F. Opoka, R. O. Tagoola, A. Oyella, S. Nalwanga, D. Nabawanuka, E. Okiror, W. Nakuya, M. Amorut, D. Muhindo, R. Ayub, Mpoya Mnjalla, H. Oguda, E. Williams, T. N. Harrison, D. A. Rowan, K. Briend, A. Maitland, K.
EClinicalMedicine, (2024). 72:102640

Characteristics of children readmitted with severe pneumonia in Kenyan hospitals.Marangu-Boore, D. Mwaniki, P. Isaaka, L. Njoroge, T. Mumelo, L. Kimego, D. Adem, A. Jowi, E. Ithondeka, A. Wanyama, C. Agweyu, A.
BMC Public Health, (2024). 24:1324

Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.Aygun, B. Lane, A. Smart, L. R. Santos, B. Tshilolo, L. Williams, T. N. Olupot-Olupot, P. Stuber, S. E. Tomlinson, G. Latham, T. Ware, R. E. Reach Investigators
Lancet Haematol, (2024). 11:e425-e435